vs

Side-by-side financial comparison of Dolby Laboratories, Inc. (DLB) and Real Brokerage Inc (REAX). Click either name above to swap in a different company.

Real Brokerage Inc is the larger business by last-quarter revenue ($568.5M vs $346.7M, roughly 1.6× Dolby Laboratories, Inc.). Dolby Laboratories, Inc. runs the higher net margin — 15.4% vs -0.1%, a 15.5% gap on every dollar of revenue. On growth, Real Brokerage Inc posted the faster year-over-year revenue change (52.6% vs -2.9%).

Dolby Laboratories, Inc. is an American technology corporation specializing in audio noise reduction, audio encoding/compression, spatial audio, and high-dynamic-range television (HDR) imaging. Dolby licenses its technologies to consumer electronics manufacturers.

Anywhere Real Estate Inc., formerly Realogy, was an American real estate services firm. It operated and franchised real estate brands that provided brokerage, relocation, title, insurance, and settlement services. Brands included Better Homes and Gardens Real Estate, Century 21 Real Estate, Coldwell Banker, Corcoran Group, ERA Real Estate and Sotheby's International Realty. In 2026, the company was acquired by Compass, Inc.

DLB vs REAX — Head-to-Head

Bigger by revenue
REAX
REAX
1.6× larger
REAX
$568.5M
$346.7M
DLB
Growing faster (revenue YoY)
REAX
REAX
+55.5% gap
REAX
52.6%
-2.9%
DLB
Higher net margin
DLB
DLB
15.5% more per $
DLB
15.4%
-0.1%
REAX

Income Statement — Q2 FY2026 vs Q3 FY2025

Metric
DLB
DLB
REAX
REAX
Revenue
$346.7M
$568.5M
Net Profit
$53.3M
$-447.0K
Gross Margin
87.5%
7.9%
Operating Margin
17.9%
-0.1%
Net Margin
15.4%
-0.1%
Revenue YoY
-2.9%
52.6%
Net Profit YoY
-21.4%
82.7%
EPS (diluted)
$0.55
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DLB
DLB
REAX
REAX
Q1 26
$346.7M
Q4 25
$346.7M
Q3 25
$307.0M
$568.5M
Q2 25
$315.5M
$540.7M
Q1 25
$369.6M
$354.0M
Q4 24
$357.0M
Q3 24
$304.8M
$372.5M
Q2 24
$288.8M
Net Profit
DLB
DLB
REAX
REAX
Q1 26
$53.3M
Q4 25
$53.3M
Q3 25
$49.3M
$-447.0K
Q2 25
$46.1M
$1.5M
Q1 25
$91.8M
$-5.0M
Q4 24
$67.8M
Q3 24
$58.6M
$-2.6M
Q2 24
$38.4M
Gross Margin
DLB
DLB
REAX
REAX
Q1 26
87.5%
Q4 25
87.5%
Q3 25
87.1%
7.9%
Q2 25
86.1%
8.9%
Q1 25
90.3%
9.6%
Q4 24
88.6%
Q3 24
88.8%
8.6%
Q2 24
87.7%
Operating Margin
DLB
DLB
REAX
REAX
Q1 26
17.9%
Q4 25
17.9%
Q3 25
9.7%
-0.1%
Q2 25
15.1%
0.3%
Q1 25
29.2%
-1.5%
Q4 24
22.4%
Q3 24
15.2%
-0.7%
Q2 24
12.7%
Net Margin
DLB
DLB
REAX
REAX
Q1 26
15.4%
Q4 25
15.4%
Q3 25
16.1%
-0.1%
Q2 25
14.6%
0.3%
Q1 25
24.8%
-1.4%
Q4 24
19.0%
Q3 24
19.2%
-0.7%
Q2 24
13.3%
EPS (diluted)
DLB
DLB
REAX
REAX
Q1 26
$0.55
Q4 25
$0.55
Q3 25
$0.50
$0.00
Q2 25
$0.48
$0.01
Q1 25
$0.94
$-0.02
Q4 24
$0.70
Q3 24
$0.59
$-0.01
Q2 24
$0.40

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DLB
DLB
REAX
REAX
Cash + ST InvestmentsLiquidity on hand
$644.6M
$38.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$2.6B
$53.6M
Total Assets
$3.2B
$145.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DLB
DLB
REAX
REAX
Q1 26
$644.6M
Q4 25
$644.6M
Q3 25
$702.6M
$38.7M
Q2 25
$699.3M
$49.7M
Q1 25
$626.6M
$24.7M
Q4 24
$520.8M
Q3 24
$482.0M
$22.6M
Q2 24
$869.0M
Stockholders' Equity
DLB
DLB
REAX
REAX
Q1 26
$2.6B
Q4 25
$2.6B
Q3 25
$2.6B
$53.6M
Q2 25
$2.6B
$49.2M
Q1 25
$2.6B
$32.8M
Q4 24
$2.5B
Q3 24
$2.5B
$29.8M
Q2 24
$2.4B
Total Assets
DLB
DLB
REAX
REAX
Q1 26
$3.2B
Q4 25
$3.2B
Q3 25
$3.2B
$145.2M
Q2 25
$3.2B
$149.4M
Q1 25
$3.2B
$100.5M
Q4 24
$3.2B
Q3 24
$3.1B
$102.5M
Q2 24
$3.0B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DLB
DLB
REAX
REAX
Operating Cash FlowLast quarter
$54.8M
$8.8M
Free Cash FlowOCF − Capex
$8.4M
FCF MarginFCF / Revenue
1.5%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
1.03×
TTM Free Cash FlowTrailing 4 quarters
$71.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DLB
DLB
REAX
REAX
Q1 26
$54.8M
Q4 25
$54.8M
Q3 25
$472.2M
$8.8M
Q2 25
$67.7M
$41.0M
Q1 25
$174.9M
$15.9M
Q4 24
$106.8M
Q3 24
$327.3M
$7.2M
Q2 24
$21.3M
Free Cash Flow
DLB
DLB
REAX
REAX
Q1 26
Q4 25
$50.2M
Q3 25
$435.9M
$8.4M
Q2 25
$61.3M
$40.8M
Q1 25
$168.0M
$15.7M
Q4 24
$100.0M
Q3 24
$297.2M
$6.8M
Q2 24
$13.7M
FCF Margin
DLB
DLB
REAX
REAX
Q1 26
Q4 25
14.5%
Q3 25
142.0%
1.5%
Q2 25
19.4%
7.5%
Q1 25
45.5%
4.4%
Q4 24
28.0%
Q3 24
97.5%
1.8%
Q2 24
4.7%
Capex Intensity
DLB
DLB
REAX
REAX
Q1 26
Q4 25
1.3%
Q3 25
11.8%
0.1%
Q2 25
2.0%
0.0%
Q1 25
1.9%
0.1%
Q4 24
1.9%
Q3 24
9.8%
0.1%
Q2 24
2.6%
Cash Conversion
DLB
DLB
REAX
REAX
Q1 26
1.03×
Q4 25
1.03×
Q3 25
9.57×
Q2 25
1.47×
27.13×
Q1 25
1.91×
Q4 24
1.57×
Q3 24
5.59×
Q2 24
0.55×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DLB
DLB

Licensing$319.8M92%
Products and services$26.9M8%

REAX
REAX

Segment breakdown not available.

Related Comparisons